On this page you will find any clinical guidance and treatment pathways that have been approved by GMMMG or its Subgroups.
Documents are listed alphabetically.
The ‘Document Title’, ‘Issue Date’ and ‘Review Date’ headings below are active links. Click a heading to sort in ascending or descending order.
|Document Title||Issue Date||Review Date||Status|
|Engagement with the Pharmaceutical Industry||20171213 Dec 2017||20201213 Dec 2020|
|GMMMG Appeals Policy||20171213 Dec 2017||20201213 Dec 2020|
|GMMMG Declaration of interests - form||20160913 Sep 2016||20190913 Sep 2019|
|GMMMG Declaration of interests - policy||20160913 Sep 2016||20190913 Sep 2019|
|Guidance on Rebate Schemes||20160413 Apr 2016||20190413 Apr 2019|
|Guidelines for defining Red, Amber, Green, DNP and Grey status||20210813 Aug 2021|
|High cost drug business case template||20131013 Oct 2013|
|High cost drugs service development guideline||20131013 Oct 2013|
|Management of Red Listed drugs in primary care||20190413 Apr 2019||20220413 Apr 2022|
|Rebate Scheme Application Request - for CCGs||20191213 Dec 2019||20221213 Dec 2022|
|Rebate Schemes - Ethical Framework||20191213 Dec 2019||20221213 Dec 2022|